Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a blend of therapies boost adaptive skills in kids with autism?

NCT ID NCT06477666

Symptom relief Sponsor: Sentido's CAIP & CICI Organización Terapéutica Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a therapy called Sentido's Model in 24 children aged 3 to 7 with autism or other neurodevelopmental challenges. The therapy combines behavior analysis, sensory integration, and stress science to help children improve adaptive behaviors like communication and daily living skills. Researchers measured changes using standard assessments and family surveys over 17 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Sentido's Model (behavioral therapy combining Applied Behavior Analysis, Ayres Sensory Integration, and Psychoimmunoendocrinology)
What this could lead to
If this approach proves effective, it could offer a structured therapy option to help children with autism and related conditions gain daily living skills and improve family well-being.
What could go wrong
This is a small, completed study with only 24 children and no comparison group, so results may not apply broadly. The therapy is complex and requires specialized training, limiting widespread use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

24 people

The number who actually took part.

Started

Oct 2023

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

3 to 7 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Informed consent signed by the parent or guardian. 2. Complete the executive admission requirements (see ANNEX). 3. Meet the diagnostic impression criteria for DSM-V neurodevelopmental disorders: * Intellectual disability (ID); global developmental delay (RDSM) or psychomotor delay (PMR); * Communication disorders: language disorders (TL), speech disorders, social communication disorder (SUD), childhood-onset disfluency; * Autism spectrum disorder (ASD) * Attention-deficit/hyperactivity disorder (ADHD) - Motor development disorders: developmental coordination disorder (DCD), stereotypic movement disorder, tic disorders, Tourette's disorder (TT), chronic tic disorder (CTT), transient tic disorder; * Specific learning disorders ( TAp ). 4. Answer the GAS, Vineland-3 and FOS scales, at therapeutic admission. 5. Willingness of significant caregivers to accompany the intervention process, for twelve sessions according to syllabus protocol. Exclusion Criteria: 1. Childhoods that exceed the age of 7 years in the study period. 2. Children diagnosed with neurological or genetic diseases, brain injury, visual, auditory or motor sensory deficits. 3. Children who are under the guardianship of the Argentine State.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adaptive behaviors are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

autism autism spectrum disorder neurodevelopmental disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adaptive behaviors Autism spectrum disorder Neurodevelopmental disorders

Contacts and locations

Locations

  • Organización Terapéutica Sentido´s CAIP&CICI (Centro de Atención Integral Pediátrico y Centro de Intervención Conductual Intensiva)

    Comodoro Rivadavia, Chubut Province, 9000, Argentina

More trials for these conditions

Other studies related to the condition(s) this trial covers.